Kristen Jogerst, Chi Zhang, Yu-Hui Chang, Sami Abujbarah, Mariam Ali-Mucheru, Barbara Pockaj, Chee-Chee Stucky, Patricia Cronin, Nabil Wasif
BACKGROUND: Disparities in cancer outcomes for minoritized people and groups experiencing disadvantages with Stage IV cancer is largely unknown. METHODS: Patients with Stage IV pancreatic, colorectal, lung, breast, and prostate cancer were identified from 2004 to 2015 in the National Cancer Database. Cox proportional hazard models were used to quantify how demographics and treatments received were associated with overall survival. RESULTS: 903,151 patients were included...
March 11, 2023: American Journal of Surgery